Electrical Stimulation Therapy
Electrical Stimulation Therapy

Electrical Stimulation Therapy Comprehensive Study by Type (Transcutaneous Electrical Neuromuscular Stimulation (TENS), Iontophoresis, Neuromuscular Electrical Stimulation (NMES), Russian Stimulation, Interferential Current (IFC), High Voltage Galvanic Current (HVGC), Others), Application (Orthopedics Disorder, Muscle Weakness or Paralysis, Stroke and Traumatic brain Injury, Spinal Cord Injury, Acute and Chronic Edema, Others), End User (Hospitals, Physiotherapy Clinics, Ambulatory Centers, Others) Players and Region - Global Market Outlook to 2026

Electrical Stimulation Therapy Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026  

Aug 2021 Edition 206 Pages 200 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
What is Electrical Stimulation Therapy Market?

Electrical stimulation is a sort of physical therapy technique that can be meant to treat with a variety of physical therapy tasks (PT). Electrical pulses are used in Electrical Stimulator to imitate the effect of neuronal messages. Muscles or nerves are targeted by these modest electrical currents. It is applied for accident or disease that causes discomfort or reduced functional movement. Electrical stimulation can be used to contract muscles that are weak or don't work properly. Electrical Stimulation can also be utilized to aid with pain and spasm relief.

The market study is being classified by Type (Transcutaneous Electrical Neuromuscular Stimulation (TENS), Iontophoresis, Neuromuscular Electrical Stimulation (NMES), Russian Stimulation, Interferential Current (IFC), High Voltage Galvanic Current (HVGC) and Others), by Application (Orthopedics Disorder, Muscle Weakness or Paralysis, Stroke and Traumatic brain Injury, Spinal Cord Injury, Acute and Chronic Edema and Others) and major geographies with country level break-up.

Boston Scientific (United States), Abbott (United States), Bioventus (United States), Medtronic (Ireland), Myolyn (United States), Cyberonics (United States), DJO Global (United States), Bioness Inc. (United States), Nevro (United States) and NeuroMetrix (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Cogentix Medical (United States), Zynex (United States) and Omron Corporation (Japan).

Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Electrical Stimulation Therapy market throughout the predicted period.

Segment Analysis
Analyst at AMA have segmented the market study of Global Electrical Stimulation Therapy market by Type, Application and Region.

On the basis of geography, the market of Electrical Stimulation Therapy has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Increasing Awareness Regarding Efficient Treatment to Treat Chronic Pain and Neurological Disorder
  • Increasing Healthcare Issues Such as Back Pain, Neurological & Movement Disorder and, Sedentary Lifestyle

Market Trend
  • The advent of Advanced Technologies and the New Devices for Reducing Pain to Considerable Extend

Restraints
  • Growing Cost of Treatment Unaffordable by Middle Low-Income Countries Can Constrain the Electrical Stimulation Therapy Market

Opportunities
  • Enhancement of Customization in Therapy and Real-Time Monitoring Can Stimulate the Growth of the Electrical Stimulation Therapy Market
  • Growing Research and Development Activities, Increasing Adoption of Stimulators will Boost the Electrical Stimulation Therapy Market

Challenges
  • Risk of Muscle Tearing, Tissue Burn or Skin Irritation can hamper the Electrical Stimulation Therapy Market


Market Leaders and some development strategies
On 31 March 2021, Bioventus announce the acquisition of Bioness Inc. This acquisition will help traumatic brain injury, multiple sclerosis, or osteoarthritis, Bioness' nerve stimulation therapy and rehabilitation devices are said to assist patients to restore their lifestyle and mobility after stroke. By using a current global network of roughly 300 salespeople calling on orthopedic, pain, and podiatric physicians, as well as extending market access and reimbursement processing capabilities, the acquisition aims to accelerate Bioness' revenue growth.

“As per National Library of Medicine, National Center for Biotechnology Information guidelines the most effective electrical stimulation treatment for knee OA is neuromuscular electrical stimulation, which is even more successful when coupled with a strengthening program. NMES is delivered by a number of devices, including battery-operated, portable devices that exclusively deliver NMES and combination units that deliver NMES and additional electrical currents including TENS, interferential current treatment, and high-voltage pulsed current therapy (HVPC). NMES may also be used with AC-powered (plug-in) devices that, in addition to providing various waveforms, also provide additional modalities such as ultrasonography. Although different outcomes are assessed, the ideal parameters for controlling severe muscular weakness and atrophy, as well as the deconditioning associated with critical illness and advanced cardiac disease, are typically comparable to those utilized post-stroke.”

Key Target Audience
Electrical Stimulation Therapy Manufactures, Electrical Stimulation Therapy Distributors and Suppliers, Research and Development Institutes, Upstream and Downstream Buyers, Financial Institutes and Investors, Regulatory Bodies and Others

Frequently Asked Questions (FAQ):

1. Which factors would majorly drive the Electrical Stimulation Therapy Market?
"Increasing Awareness Regarding Efficient Treatment to Treat Chronic Pain and Neurological Disorder " is seen as one of major growth factors of Electrical Stimulation Therapy Market in years to come.

2. Can we have customized study for Electrical Stimulation Therapy Market?
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.

3. Which region will lead the Global Electrical Stimulation Therapy Market?
will lead the Electrical Stimulation Therapy Market.
Report Objectives / Segmentation Covered
By Type
  • Transcutaneous Electrical Neuromuscular Stimulation (TENS)
  • Iontophoresis
  • Neuromuscular Electrical Stimulation (NMES)
  • Russian Stimulation
  • Interferential Current (IFC)
  • High Voltage Galvanic Current (HVGC)
  • Others
By Application
  • Orthopedics Disorder
  • Muscle Weakness or Paralysis
  • Stroke and Traumatic brain Injury
  • Spinal Cord Injury
  • Acute and Chronic Edema
  • Others
By End User
  • Hospitals
  • Physiotherapy Clinics
  • Ambulatory Centers
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Awareness Regarding Efficient Treatment to Treat Chronic Pain and Neurological Disorder
      • 3.2.2. Increasing Healthcare Issues Such as Back Pain, Neurological & Movement Disorder and, Sedentary Lifestyle
    • 3.3. Market Challenges
      • 3.3.1. Risk of Muscle Tearing, Tissue Burn or Skin Irritation can hamper the Electrical Stimulation Therapy Market
    • 3.4. Market Trends
      • 3.4.1. The advent of Advanced Technologies and the New Devices for Reducing Pain to Considerable Extend
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Electrical Stimulation Therapy, by Type, Application, End User and Region (value and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Electrical Stimulation Therapy (Value)
      • 5.2.1. Global Electrical Stimulation Therapy by: Type (Value)
        • 5.2.1.1. Transcutaneous Electrical Neuromuscular Stimulation (TENS)
        • 5.2.1.2. Iontophoresis
        • 5.2.1.3. Neuromuscular Electrical Stimulation (NMES)
        • 5.2.1.4. Russian Stimulation
        • 5.2.1.5. Interferential Current (IFC)
        • 5.2.1.6. High Voltage Galvanic Current (HVGC)
        • 5.2.1.7. Others
      • 5.2.2. Global Electrical Stimulation Therapy by: Application (Value)
        • 5.2.2.1. Orthopedics Disorder
        • 5.2.2.2. Muscle Weakness or Paralysis
        • 5.2.2.3. Stroke and Traumatic brain Injury
        • 5.2.2.4. Spinal Cord Injury
        • 5.2.2.5. Acute and Chronic Edema
        • 5.2.2.6. Others
      • 5.2.3. Global Electrical Stimulation Therapy by: End User (Value)
        • 5.2.3.1. Hospitals
        • 5.2.3.2. Physiotherapy Clinics
        • 5.2.3.3. Ambulatory Centers
        • 5.2.3.4. Others
      • 5.2.4. Global Electrical Stimulation Therapy Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Electrical Stimulation Therapy (Price)
      • 5.3.1. Global Electrical Stimulation Therapy by: Type (Price)
  • 6. Electrical Stimulation Therapy: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Boston Scientific (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Abbott (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Bioventus (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Medtronic (Ireland)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Myolyn (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Cyberonics (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. DJO Global (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Bioness Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Nevro (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. NeuroMetrix (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Electrical Stimulation Therapy Sale, by Type, Application, End User and Region (value and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Electrical Stimulation Therapy (Value)
      • 7.2.1. Global Electrical Stimulation Therapy by: Type (Value)
        • 7.2.1.1. Transcutaneous Electrical Neuromuscular Stimulation (TENS)
        • 7.2.1.2. Iontophoresis
        • 7.2.1.3. Neuromuscular Electrical Stimulation (NMES)
        • 7.2.1.4. Russian Stimulation
        • 7.2.1.5. Interferential Current (IFC)
        • 7.2.1.6. High Voltage Galvanic Current (HVGC)
        • 7.2.1.7. Others
      • 7.2.2. Global Electrical Stimulation Therapy by: Application (Value)
        • 7.2.2.1. Orthopedics Disorder
        • 7.2.2.2. Muscle Weakness or Paralysis
        • 7.2.2.3. Stroke and Traumatic brain Injury
        • 7.2.2.4. Spinal Cord Injury
        • 7.2.2.5. Acute and Chronic Edema
        • 7.2.2.6. Others
      • 7.2.3. Global Electrical Stimulation Therapy by: End User (Value)
        • 7.2.3.1. Hospitals
        • 7.2.3.2. Physiotherapy Clinics
        • 7.2.3.3. Ambulatory Centers
        • 7.2.3.4. Others
      • 7.2.4. Global Electrical Stimulation Therapy Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Electrical Stimulation Therapy (Price)
      • 7.3.1. Global Electrical Stimulation Therapy by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Electrical Stimulation Therapy: by Type(USD N)
  • Table 2. Electrical Stimulation Therapy Transcutaneous Electrical Neuromuscular Stimulation (TENS) , by Region USD N (2015-2020)
  • Table 3. Electrical Stimulation Therapy Iontophoresis , by Region USD N (2015-2020)
  • Table 4. Electrical Stimulation Therapy Neuromuscular Electrical Stimulation (NMES) , by Region USD N (2015-2020)
  • Table 5. Electrical Stimulation Therapy Russian Stimulation , by Region USD N (2015-2020)
  • Table 6. Electrical Stimulation Therapy Interferential Current (IFC) , by Region USD N (2015-2020)
  • Table 7. Electrical Stimulation Therapy High Voltage Galvanic Current (HVGC) , by Region USD N (2015-2020)
  • Table 8. Electrical Stimulation Therapy Others , by Region USD N (2015-2020)
  • Table 9. Electrical Stimulation Therapy: by Application(USD N)
  • Table 10. Electrical Stimulation Therapy Orthopedics Disorder , by Region USD N (2015-2020)
  • Table 11. Electrical Stimulation Therapy Muscle Weakness or Paralysis , by Region USD N (2015-2020)
  • Table 12. Electrical Stimulation Therapy Stroke and Traumatic brain Injury , by Region USD N (2015-2020)
  • Table 13. Electrical Stimulation Therapy Spinal Cord Injury , by Region USD N (2015-2020)
  • Table 14. Electrical Stimulation Therapy Acute and Chronic Edema , by Region USD N (2015-2020)
  • Table 15. Electrical Stimulation Therapy Others , by Region USD N (2015-2020)
  • Table 16. Electrical Stimulation Therapy: by End User(USD N)
  • Table 17. Electrical Stimulation Therapy Hospitals , by Region USD N (2015-2020)
  • Table 18. Electrical Stimulation Therapy Physiotherapy Clinics , by Region USD N (2015-2020)
  • Table 19. Electrical Stimulation Therapy Ambulatory Centers , by Region USD N (2015-2020)
  • Table 20. Electrical Stimulation Therapy Others , by Region USD N (2015-2020)
  • Table 21. South America Electrical Stimulation Therapy, by Country USD N (2015-2020)
  • Table 22. South America Electrical Stimulation Therapy, by Type USD N (2015-2020)
  • Table 23. South America Electrical Stimulation Therapy, by Application USD N (2015-2020)
  • Table 24. South America Electrical Stimulation Therapy, by End User USD N (2015-2020)
  • Table 25. Brazil Electrical Stimulation Therapy, by Type USD N (2015-2020)
  • Table 26. Brazil Electrical Stimulation Therapy, by Application USD N (2015-2020)
  • Table 27. Brazil Electrical Stimulation Therapy, by End User USD N (2015-2020)
  • Table 28. Argentina Electrical Stimulation Therapy, by Type USD N (2015-2020)
  • Table 29. Argentina Electrical Stimulation Therapy, by Application USD N (2015-2020)
  • Table 30. Argentina Electrical Stimulation Therapy, by End User USD N (2015-2020)
  • Table 31. Rest of South America Electrical Stimulation Therapy, by Type USD N (2015-2020)
  • Table 32. Rest of South America Electrical Stimulation Therapy, by Application USD N (2015-2020)
  • Table 33. Rest of South America Electrical Stimulation Therapy, by End User USD N (2015-2020)
  • Table 34. Asia Pacific Electrical Stimulation Therapy, by Country USD N (2015-2020)
  • Table 35. Asia Pacific Electrical Stimulation Therapy, by Type USD N (2015-2020)
  • Table 36. Asia Pacific Electrical Stimulation Therapy, by Application USD N (2015-2020)
  • Table 37. Asia Pacific Electrical Stimulation Therapy, by End User USD N (2015-2020)
  • Table 38. China Electrical Stimulation Therapy, by Type USD N (2015-2020)
  • Table 39. China Electrical Stimulation Therapy, by Application USD N (2015-2020)
  • Table 40. China Electrical Stimulation Therapy, by End User USD N (2015-2020)
  • Table 41. Japan Electrical Stimulation Therapy, by Type USD N (2015-2020)
  • Table 42. Japan Electrical Stimulation Therapy, by Application USD N (2015-2020)
  • Table 43. Japan Electrical Stimulation Therapy, by End User USD N (2015-2020)
  • Table 44. India Electrical Stimulation Therapy, by Type USD N (2015-2020)
  • Table 45. India Electrical Stimulation Therapy, by Application USD N (2015-2020)
  • Table 46. India Electrical Stimulation Therapy, by End User USD N (2015-2020)
  • Table 47. South Korea Electrical Stimulation Therapy, by Type USD N (2015-2020)
  • Table 48. South Korea Electrical Stimulation Therapy, by Application USD N (2015-2020)
  • Table 49. South Korea Electrical Stimulation Therapy, by End User USD N (2015-2020)
  • Table 50. Taiwan Electrical Stimulation Therapy, by Type USD N (2015-2020)
  • Table 51. Taiwan Electrical Stimulation Therapy, by Application USD N (2015-2020)
  • Table 52. Taiwan Electrical Stimulation Therapy, by End User USD N (2015-2020)
  • Table 53. Australia Electrical Stimulation Therapy, by Type USD N (2015-2020)
  • Table 54. Australia Electrical Stimulation Therapy, by Application USD N (2015-2020)
  • Table 55. Australia Electrical Stimulation Therapy, by End User USD N (2015-2020)
  • Table 56. Rest of Asia-Pacific Electrical Stimulation Therapy, by Type USD N (2015-2020)
  • Table 57. Rest of Asia-Pacific Electrical Stimulation Therapy, by Application USD N (2015-2020)
  • Table 58. Rest of Asia-Pacific Electrical Stimulation Therapy, by End User USD N (2015-2020)
  • Table 59. Europe Electrical Stimulation Therapy, by Country USD N (2015-2020)
  • Table 60. Europe Electrical Stimulation Therapy, by Type USD N (2015-2020)
  • Table 61. Europe Electrical Stimulation Therapy, by Application USD N (2015-2020)
  • Table 62. Europe Electrical Stimulation Therapy, by End User USD N (2015-2020)
  • Table 63. Germany Electrical Stimulation Therapy, by Type USD N (2015-2020)
  • Table 64. Germany Electrical Stimulation Therapy, by Application USD N (2015-2020)
  • Table 65. Germany Electrical Stimulation Therapy, by End User USD N (2015-2020)
  • Table 66. France Electrical Stimulation Therapy, by Type USD N (2015-2020)
  • Table 67. France Electrical Stimulation Therapy, by Application USD N (2015-2020)
  • Table 68. France Electrical Stimulation Therapy, by End User USD N (2015-2020)
  • Table 69. Italy Electrical Stimulation Therapy, by Type USD N (2015-2020)
  • Table 70. Italy Electrical Stimulation Therapy, by Application USD N (2015-2020)
  • Table 71. Italy Electrical Stimulation Therapy, by End User USD N (2015-2020)
  • Table 72. United Kingdom Electrical Stimulation Therapy, by Type USD N (2015-2020)
  • Table 73. United Kingdom Electrical Stimulation Therapy, by Application USD N (2015-2020)
  • Table 74. United Kingdom Electrical Stimulation Therapy, by End User USD N (2015-2020)
  • Table 75. Netherlands Electrical Stimulation Therapy, by Type USD N (2015-2020)
  • Table 76. Netherlands Electrical Stimulation Therapy, by Application USD N (2015-2020)
  • Table 77. Netherlands Electrical Stimulation Therapy, by End User USD N (2015-2020)
  • Table 78. Rest of Europe Electrical Stimulation Therapy, by Type USD N (2015-2020)
  • Table 79. Rest of Europe Electrical Stimulation Therapy, by Application USD N (2015-2020)
  • Table 80. Rest of Europe Electrical Stimulation Therapy, by End User USD N (2015-2020)
  • Table 81. MEA Electrical Stimulation Therapy, by Country USD N (2015-2020)
  • Table 82. MEA Electrical Stimulation Therapy, by Type USD N (2015-2020)
  • Table 83. MEA Electrical Stimulation Therapy, by Application USD N (2015-2020)
  • Table 84. MEA Electrical Stimulation Therapy, by End User USD N (2015-2020)
  • Table 85. Middle East Electrical Stimulation Therapy, by Type USD N (2015-2020)
  • Table 86. Middle East Electrical Stimulation Therapy, by Application USD N (2015-2020)
  • Table 87. Middle East Electrical Stimulation Therapy, by End User USD N (2015-2020)
  • Table 88. Africa Electrical Stimulation Therapy, by Type USD N (2015-2020)
  • Table 89. Africa Electrical Stimulation Therapy, by Application USD N (2015-2020)
  • Table 90. Africa Electrical Stimulation Therapy, by End User USD N (2015-2020)
  • Table 91. North America Electrical Stimulation Therapy, by Country USD N (2015-2020)
  • Table 92. North America Electrical Stimulation Therapy, by Type USD N (2015-2020)
  • Table 93. North America Electrical Stimulation Therapy, by Application USD N (2015-2020)
  • Table 94. North America Electrical Stimulation Therapy, by End User USD N (2015-2020)
  • Table 95. United States Electrical Stimulation Therapy, by Type USD N (2015-2020)
  • Table 96. United States Electrical Stimulation Therapy, by Application USD N (2015-2020)
  • Table 97. United States Electrical Stimulation Therapy, by End User USD N (2015-2020)
  • Table 98. Canada Electrical Stimulation Therapy, by Type USD N (2015-2020)
  • Table 99. Canada Electrical Stimulation Therapy, by Application USD N (2015-2020)
  • Table 100. Canada Electrical Stimulation Therapy, by End User USD N (2015-2020)
  • Table 101. Mexico Electrical Stimulation Therapy, by Type USD N (2015-2020)
  • Table 102. Mexico Electrical Stimulation Therapy, by Application USD N (2015-2020)
  • Table 103. Mexico Electrical Stimulation Therapy, by End User USD N (2015-2020)
  • Table 104. Electrical Stimulation Therapy: by Type(USD/Units)
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Company Basic Information, Sales Area and Its Competitors
  • Table 111. Company Basic Information, Sales Area and Its Competitors
  • Table 112. Company Basic Information, Sales Area and Its Competitors
  • Table 113. Company Basic Information, Sales Area and Its Competitors
  • Table 114. Company Basic Information, Sales Area and Its Competitors
  • Table 115. Electrical Stimulation Therapy: by Type(USD N)
  • Table 116. Electrical Stimulation Therapy Transcutaneous Electrical Neuromuscular Stimulation (TENS) , by Region USD N (2021-2026)
  • Table 117. Electrical Stimulation Therapy Iontophoresis , by Region USD N (2021-2026)
  • Table 118. Electrical Stimulation Therapy Neuromuscular Electrical Stimulation (NMES) , by Region USD N (2021-2026)
  • Table 119. Electrical Stimulation Therapy Russian Stimulation , by Region USD N (2021-2026)
  • Table 120. Electrical Stimulation Therapy Interferential Current (IFC) , by Region USD N (2021-2026)
  • Table 121. Electrical Stimulation Therapy High Voltage Galvanic Current (HVGC) , by Region USD N (2021-2026)
  • Table 122. Electrical Stimulation Therapy Others , by Region USD N (2021-2026)
  • Table 123. Electrical Stimulation Therapy: by Application(USD N)
  • Table 124. Electrical Stimulation Therapy Orthopedics Disorder , by Region USD N (2021-2026)
  • Table 125. Electrical Stimulation Therapy Muscle Weakness or Paralysis , by Region USD N (2021-2026)
  • Table 126. Electrical Stimulation Therapy Stroke and Traumatic brain Injury , by Region USD N (2021-2026)
  • Table 127. Electrical Stimulation Therapy Spinal Cord Injury , by Region USD N (2021-2026)
  • Table 128. Electrical Stimulation Therapy Acute and Chronic Edema , by Region USD N (2021-2026)
  • Table 129. Electrical Stimulation Therapy Others , by Region USD N (2021-2026)
  • Table 130. Electrical Stimulation Therapy: by End User(USD N)
  • Table 131. Electrical Stimulation Therapy Hospitals , by Region USD N (2021-2026)
  • Table 132. Electrical Stimulation Therapy Physiotherapy Clinics , by Region USD N (2021-2026)
  • Table 133. Electrical Stimulation Therapy Ambulatory Centers , by Region USD N (2021-2026)
  • Table 134. Electrical Stimulation Therapy Others , by Region USD N (2021-2026)
  • Table 135. South America Electrical Stimulation Therapy, by Country USD N (2021-2026)
  • Table 136. South America Electrical Stimulation Therapy, by Type USD N (2021-2026)
  • Table 137. South America Electrical Stimulation Therapy, by Application USD N (2021-2026)
  • Table 138. South America Electrical Stimulation Therapy, by End User USD N (2021-2026)
  • Table 139. Brazil Electrical Stimulation Therapy, by Type USD N (2021-2026)
  • Table 140. Brazil Electrical Stimulation Therapy, by Application USD N (2021-2026)
  • Table 141. Brazil Electrical Stimulation Therapy, by End User USD N (2021-2026)
  • Table 142. Argentina Electrical Stimulation Therapy, by Type USD N (2021-2026)
  • Table 143. Argentina Electrical Stimulation Therapy, by Application USD N (2021-2026)
  • Table 144. Argentina Electrical Stimulation Therapy, by End User USD N (2021-2026)
  • Table 145. Rest of South America Electrical Stimulation Therapy, by Type USD N (2021-2026)
  • Table 146. Rest of South America Electrical Stimulation Therapy, by Application USD N (2021-2026)
  • Table 147. Rest of South America Electrical Stimulation Therapy, by End User USD N (2021-2026)
  • Table 148. Asia Pacific Electrical Stimulation Therapy, by Country USD N (2021-2026)
  • Table 149. Asia Pacific Electrical Stimulation Therapy, by Type USD N (2021-2026)
  • Table 150. Asia Pacific Electrical Stimulation Therapy, by Application USD N (2021-2026)
  • Table 151. Asia Pacific Electrical Stimulation Therapy, by End User USD N (2021-2026)
  • Table 152. China Electrical Stimulation Therapy, by Type USD N (2021-2026)
  • Table 153. China Electrical Stimulation Therapy, by Application USD N (2021-2026)
  • Table 154. China Electrical Stimulation Therapy, by End User USD N (2021-2026)
  • Table 155. Japan Electrical Stimulation Therapy, by Type USD N (2021-2026)
  • Table 156. Japan Electrical Stimulation Therapy, by Application USD N (2021-2026)
  • Table 157. Japan Electrical Stimulation Therapy, by End User USD N (2021-2026)
  • Table 158. India Electrical Stimulation Therapy, by Type USD N (2021-2026)
  • Table 159. India Electrical Stimulation Therapy, by Application USD N (2021-2026)
  • Table 160. India Electrical Stimulation Therapy, by End User USD N (2021-2026)
  • Table 161. South Korea Electrical Stimulation Therapy, by Type USD N (2021-2026)
  • Table 162. South Korea Electrical Stimulation Therapy, by Application USD N (2021-2026)
  • Table 163. South Korea Electrical Stimulation Therapy, by End User USD N (2021-2026)
  • Table 164. Taiwan Electrical Stimulation Therapy, by Type USD N (2021-2026)
  • Table 165. Taiwan Electrical Stimulation Therapy, by Application USD N (2021-2026)
  • Table 166. Taiwan Electrical Stimulation Therapy, by End User USD N (2021-2026)
  • Table 167. Australia Electrical Stimulation Therapy, by Type USD N (2021-2026)
  • Table 168. Australia Electrical Stimulation Therapy, by Application USD N (2021-2026)
  • Table 169. Australia Electrical Stimulation Therapy, by End User USD N (2021-2026)
  • Table 170. Rest of Asia-Pacific Electrical Stimulation Therapy, by Type USD N (2021-2026)
  • Table 171. Rest of Asia-Pacific Electrical Stimulation Therapy, by Application USD N (2021-2026)
  • Table 172. Rest of Asia-Pacific Electrical Stimulation Therapy, by End User USD N (2021-2026)
  • Table 173. Europe Electrical Stimulation Therapy, by Country USD N (2021-2026)
  • Table 174. Europe Electrical Stimulation Therapy, by Type USD N (2021-2026)
  • Table 175. Europe Electrical Stimulation Therapy, by Application USD N (2021-2026)
  • Table 176. Europe Electrical Stimulation Therapy, by End User USD N (2021-2026)
  • Table 177. Germany Electrical Stimulation Therapy, by Type USD N (2021-2026)
  • Table 178. Germany Electrical Stimulation Therapy, by Application USD N (2021-2026)
  • Table 179. Germany Electrical Stimulation Therapy, by End User USD N (2021-2026)
  • Table 180. France Electrical Stimulation Therapy, by Type USD N (2021-2026)
  • Table 181. France Electrical Stimulation Therapy, by Application USD N (2021-2026)
  • Table 182. France Electrical Stimulation Therapy, by End User USD N (2021-2026)
  • Table 183. Italy Electrical Stimulation Therapy, by Type USD N (2021-2026)
  • Table 184. Italy Electrical Stimulation Therapy, by Application USD N (2021-2026)
  • Table 185. Italy Electrical Stimulation Therapy, by End User USD N (2021-2026)
  • Table 186. United Kingdom Electrical Stimulation Therapy, by Type USD N (2021-2026)
  • Table 187. United Kingdom Electrical Stimulation Therapy, by Application USD N (2021-2026)
  • Table 188. United Kingdom Electrical Stimulation Therapy, by End User USD N (2021-2026)
  • Table 189. Netherlands Electrical Stimulation Therapy, by Type USD N (2021-2026)
  • Table 190. Netherlands Electrical Stimulation Therapy, by Application USD N (2021-2026)
  • Table 191. Netherlands Electrical Stimulation Therapy, by End User USD N (2021-2026)
  • Table 192. Rest of Europe Electrical Stimulation Therapy, by Type USD N (2021-2026)
  • Table 193. Rest of Europe Electrical Stimulation Therapy, by Application USD N (2021-2026)
  • Table 194. Rest of Europe Electrical Stimulation Therapy, by End User USD N (2021-2026)
  • Table 195. MEA Electrical Stimulation Therapy, by Country USD N (2021-2026)
  • Table 196. MEA Electrical Stimulation Therapy, by Type USD N (2021-2026)
  • Table 197. MEA Electrical Stimulation Therapy, by Application USD N (2021-2026)
  • Table 198. MEA Electrical Stimulation Therapy, by End User USD N (2021-2026)
  • Table 199. Middle East Electrical Stimulation Therapy, by Type USD N (2021-2026)
  • Table 200. Middle East Electrical Stimulation Therapy, by Application USD N (2021-2026)
  • Table 201. Middle East Electrical Stimulation Therapy, by End User USD N (2021-2026)
  • Table 202. Africa Electrical Stimulation Therapy, by Type USD N (2021-2026)
  • Table 203. Africa Electrical Stimulation Therapy, by Application USD N (2021-2026)
  • Table 204. Africa Electrical Stimulation Therapy, by End User USD N (2021-2026)
  • Table 205. North America Electrical Stimulation Therapy, by Country USD N (2021-2026)
  • Table 206. North America Electrical Stimulation Therapy, by Type USD N (2021-2026)
  • Table 207. North America Electrical Stimulation Therapy, by Application USD N (2021-2026)
  • Table 208. North America Electrical Stimulation Therapy, by End User USD N (2021-2026)
  • Table 209. United States Electrical Stimulation Therapy, by Type USD N (2021-2026)
  • Table 210. United States Electrical Stimulation Therapy, by Application USD N (2021-2026)
  • Table 211. United States Electrical Stimulation Therapy, by End User USD N (2021-2026)
  • Table 212. Canada Electrical Stimulation Therapy, by Type USD N (2021-2026)
  • Table 213. Canada Electrical Stimulation Therapy, by Application USD N (2021-2026)
  • Table 214. Canada Electrical Stimulation Therapy, by End User USD N (2021-2026)
  • Table 215. Mexico Electrical Stimulation Therapy, by Type USD N (2021-2026)
  • Table 216. Mexico Electrical Stimulation Therapy, by Application USD N (2021-2026)
  • Table 217. Mexico Electrical Stimulation Therapy, by End User USD N (2021-2026)
  • Table 218. Electrical Stimulation Therapy: by Type(USD/Units)
  • Table 219. Research Programs/Design for This Report
  • Table 220. Key Data Information from Secondary Sources
  • Table 221. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Electrical Stimulation Therapy: by Type USD N (2015-2020)
  • Figure 5. Global Electrical Stimulation Therapy: by Application USD N (2015-2020)
  • Figure 6. Global Electrical Stimulation Therapy: by End User USD N (2015-2020)
  • Figure 7. South America Electrical Stimulation Therapy Share (%), by Country
  • Figure 8. Asia Pacific Electrical Stimulation Therapy Share (%), by Country
  • Figure 9. Europe Electrical Stimulation Therapy Share (%), by Country
  • Figure 10. MEA Electrical Stimulation Therapy Share (%), by Country
  • Figure 11. North America Electrical Stimulation Therapy Share (%), by Country
  • Figure 12. Global Electrical Stimulation Therapy: by Type USD/Units (2015-2020)
  • Figure 13. Global Electrical Stimulation Therapy share by Players 2020 (%)
  • Figure 14. Global Electrical Stimulation Therapy share by Players (Top 3) 2020(%)
  • Figure 15. Global Electrical Stimulation Therapy share by Players (Top 5) 2020(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Boston Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 18. Boston Scientific (United States) Revenue: by Geography 2020
  • Figure 19. Abbott (United States) Revenue, Net Income and Gross profit
  • Figure 20. Abbott (United States) Revenue: by Geography 2020
  • Figure 21. Bioventus (United States) Revenue, Net Income and Gross profit
  • Figure 22. Bioventus (United States) Revenue: by Geography 2020
  • Figure 23. Medtronic (Ireland) Revenue, Net Income and Gross profit
  • Figure 24. Medtronic (Ireland) Revenue: by Geography 2020
  • Figure 25. Myolyn (United States) Revenue, Net Income and Gross profit
  • Figure 26. Myolyn (United States) Revenue: by Geography 2020
  • Figure 27. Cyberonics (United States) Revenue, Net Income and Gross profit
  • Figure 28. Cyberonics (United States) Revenue: by Geography 2020
  • Figure 29. DJO Global (United States) Revenue, Net Income and Gross profit
  • Figure 30. DJO Global (United States) Revenue: by Geography 2020
  • Figure 31. Bioness Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 32. Bioness Inc. (United States) Revenue: by Geography 2020
  • Figure 33. Nevro (United States) Revenue, Net Income and Gross profit
  • Figure 34. Nevro (United States) Revenue: by Geography 2020
  • Figure 35. NeuroMetrix (United States) Revenue, Net Income and Gross profit
  • Figure 36. NeuroMetrix (United States) Revenue: by Geography 2020
  • Figure 37. Global Electrical Stimulation Therapy: by Type USD N (2021-2026)
  • Figure 38. Global Electrical Stimulation Therapy: by Application USD N (2021-2026)
  • Figure 39. Global Electrical Stimulation Therapy: by End User USD N (2021-2026)
  • Figure 40. South America Electrical Stimulation Therapy Share (%), by Country
  • Figure 41. Asia Pacific Electrical Stimulation Therapy Share (%), by Country
  • Figure 42. Europe Electrical Stimulation Therapy Share (%), by Country
  • Figure 43. MEA Electrical Stimulation Therapy Share (%), by Country
  • Figure 44. North America Electrical Stimulation Therapy Share (%), by Country
  • Figure 45. Global Electrical Stimulation Therapy: by Type USD/Units (2021-2026)
Some of the key companies/manufacturers profiled in the report
  • Boston Scientific (United States)
  • Abbott (United States)
  • Bioventus (United States)
  • Medtronic (Ireland)
  • Myolyn (United States)
  • Cyberonics (United States)
  • DJO Global (United States)
  • Bioness Inc. (United States)
  • Nevro (United States)
  • NeuroMetrix (United States)
Additional players considered in the study are as follows:
Cogentix Medical (United States) , Zynex (United States) , Omron Corporation (Japan)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation